FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) is a fall prediction system "Coroban" that uses artificial intelligence.^®(Patent registration number: Patent No. 6652986) has been certified as a recommended product by the Japanese Society for Fall Prevention.

　This system is an epoch-making system that analyzes the nursing records of inpatients and predicts and presents the risk of falls. Our original natural language analysis AI "Concept Encoder (concept encoder)"^®, Concept encoder) ”technology was developed in collaboration with Eisai Co., Ltd.

　Based on the text information of the nursing record, the feature of picking up "awareness" of medical staff and the possibility of improving the quality and efficiency of medical safety work have been evaluated, and this system is recommended by the Japan Fall Prevention Society. Was certified as.

　FRONTEO will continue to provide peace of mind to more medical professionals and patients.^®We will continue research and development so that you can use it.

■ Coroban^®about　URL: https://lifescience.fronteo.com/operations/

Coroban^®Is a fall prediction system that uses the artificial intelligence Concept Encoder, which was developed by FRONTEO together with Eisai Co., Ltd. Concept Encoder reads the electronic medical record and evaluates the risk of falls from the patient's condition and nursing records.It is possible to make predictions with the same accuracy as the conventional fall risk evaluation sheet without increasing the burden on medical staff.Patent registration number: Patent No. 6652986

Concept Encoder reads a free-form electronic medical record and evaluates the risk of falling.

Coroban® screen.Fall risk is evaluated from nursing records with a score of 0 to 1.0 (left), and patients who require special attention are listed (right).

■ About Concept Encoder　URL: https://lifescience.fronteo.com/

"Concept Encoder (concept encoder)^®, Concept Encoder) ”is a natural language analysis AI (artificial intelligence) developed by FRONTEO specializing in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. "Concept Encoder" can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO　URL: https://www.fronteo.com/

FRONTEO Inc. has developed its own natural language analysis AI (artificial intelligence) engine "KIBIT".^®(Kibit) ”and“ concept encoder^®(Concept encoder) ”is a company that supports information analysis.Established in August 2003 as a company that supports e-discovery (electronic discovery), which preserves evidence, investigates and analyzes electronic data necessary for international proceedings, and digital forensic investigations, and technologies such as an in-house developed data analysis platform To date, we have supported about 8 international proceedings.In addition, we are applying the unique AI-related technology cultivated in the legal business to areas such as life science and business intelligence, and have achieved results in drug discovery research support, diagnostic support, and work style reform. Listed on TSE Mothers on June 1, 2007.The capital is 6 thousand yen (as of March 26, 2,559,206).